Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
2141-V11 for Prostate Cancer
Recruiting1 awardPhase 2
Montvale, New Jersey
"This trial aims to test whether adding 2141-V11 to standard prostate cancer treatments is effective. 2141-V11 activates the immune system to target and destroy cancer cells. Researchers will assess if
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.